RxDoctor Payments Data

Chad Lamb, MD

Family Medicine · Anderson, INNPI 1225066392

Payments from drug & device makers

$408in general payments, 2019–2025

Across 28 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$71
  • Novo Nordisk$62
  • Pfizer$56
  • Takeda Pharmaceuticals U.S.A., Inc.$41
  • Amarin Pharma, Inc.$31
  • Novartis$27
  • plus $121 from 7 others

What the payments were for

  • Food & beverage$408100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$408 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$75,653
Medicare patients
242
Services billed
1,515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$91,268
JanuviaSitagliptin Phosphate59$71,810
OzempicSemaglutide49$71,352
FarxigaDapagliflozin Propanediol30$36,017
MounjaroTirzepatide17$21,740
InvokanaCanagliflozin12$20,138
MyrbetriqMirabegron14$18,910
JanumetSitagliptin Phos/Metformin Hcl12$18,740
JardianceEmpagliflozin13$16,714
LinzessLinaclotide16$13,910
Tresiba Flextouch U-100Insulin Degludec13$11,451
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$10,208
PremarinEstrogens, Conjugated13$8,801
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$8,516
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$6,818

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$56$100,06992 claims
Novo NordiskOzempic$62$71,35249 claims
Lilly USA, LLCMounjaro$71$21,74017 claims
Johnson & JohnsonInvokana$18$20,13812 claims
Astellas Pharma US IncMyrbetriq$20$18,91014 claims
Boehringer IngelheimJardiance$23$16,71413 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$41$5,64712 claims
GSKArnuity Ellipta$11$4,22511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Anderson

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →